Reported Q: Q4 2024 Rev YoY: +9.1% EPS YoY: -200.3% Move: 0.00%
Precision Optics
PEYE
$1.950 0.00%
Exchange OTC Sector Healthcare Industry Medical Instruments Supplies
Q4 2024
Published: Oct 28, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for PEYE

Reported

Report Date

Oct 28, 2024

Quarter Q4 2024

Revenue

4.72M

YoY: +9.1%

EPS

-0.23

YoY: -200.3%

Market Move

0.00%

Previous quarter: Q3 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $4.72M up 9.1% year-over-year
  • EPS of $-0.23 decreased by 200.3% from previous year
  • Gross margin of 21.7%
  • Net income of -1.41M
  • "N/A" - N/A
PEYE
Company PEYE

Swipe to view all report sections

Executive Summary

- Precision Optics posted Q4 2024 results with revenue of 4.72 million, up 9.1% year-over-year but down 10.0% quarter-over-quarter, signaling a modest top-line recovery offset by margin compression in a tight cost environment. Gross profit of 1.02 million yielded a gross margin of 21.72%, a meaningful deterioration from Q4 2023 (about 35.0%), underscoring pricing/mix pressure or elevated cost of goods sold.
- Operating performance remained negative, with operating income of -1.36 million and EBITDA of -1.30 million, resulting in a net loss of -1.41 million and EPS of -0.23 for the quarter. Cash flow from operations was -0.98 million and free cash flow was -0.99 million, highlighting ongoing cash burn despite revenue strength. The company ended the period with approximately 0.405 million in cash, total debt around 3.43 million, and net debt of roughly 3.03 million, signaling near-term liquidity considerations absent a capital action or material profitability improvement.
- The balance sheet shows a solid equity base (approx. 10.07 million) and sizable goodwill/intangible assets (Goodwill 8.82 million; Intangibles 0.29 million; total noncurrent assets ~9.79 million), implying exposure to impairment risk if profitability does not improve. Near-term catalysts will likely hinge on cost-control, mix optimization toward higher-margin offerings, and potential external funding to sustain operations. Management commentary is not provided in the transcript data available for this analysis, limiting direct insight into forward-looking guidance.

Key Performance Indicators

Revenue
Increasing
4.72M
QoQ: -10.04% | YoY: 9.14%
Gross Profit
Decreasing
1.02M
21.72% margin
QoQ: -44.88% | YoY: -30.01%
Operating Income
Decreasing
-1.36M
QoQ: -424.64% | YoY: -234.66%
Net Income
Decreasing
-1.41M
QoQ: -345.07% | YoY: -203.85%
EPS
Decreasing
-0.23
QoQ: -340.61% | YoY: -200.26%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 4.19 -0.30 -20.2% View
Q2 2025 4.53 -0.15 -9.9% View
Q1 2025 4.20 -0.21 -13.0% View
Q4 2024 4.72 -0.23 +9.1% View
Q3 2024 5.24 -0.05 +3.9% View